The Cancer Drug Parity Act of 2026 aims to ensure that insurance coverage for oral anticancer medications is treated the same as coverage for anticancer treatments given by healthcare providers, such as intravenous or injected medications. The main goal is to reduce the financial burden on patients who use oral medications to treat cancer. The key provisions of this law require that health plans offering anticancer treatments must provide cost-sharing for oral anticancer drugs that is no less favorable than that for treatments administered by healthcare providers.